Mei Lin Tan

1.3k total citations
26 papers, 1.1k citations indexed

About

Mei Lin Tan is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Mei Lin Tan has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Biomaterials and 6 papers in Cancer Research. Recurrent topics in Mei Lin Tan's work include RNA Interference and Gene Delivery (7 papers), Nanoparticle-Based Drug Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Mei Lin Tan is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Nanoparticle-Based Drug Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Mei Lin Tan collaborates with scholars based in Australia, China and United States. Mei Lin Tan's co-authors include Peter Choong, Crispin R. Dass, Robert O. Wright, Rebekah Mannix, Marc N. Baskin, Crispin R Dass, Anna Friedhuber, Dave E. Dunstan, Sivanjah Indumathy and Yongzhong Wei and has published in prestigious journals such as Biomaterials, PEDIATRICS and Biochemical and Biophysical Research Communications.

In The Last Decade

Mei Lin Tan

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Lin Tan Australia 14 432 318 186 163 146 26 1.1k
Gergely Tibor Kozma Hungary 15 485 1.1× 297 0.9× 180 1.0× 127 0.8× 66 0.5× 33 1.3k
Hyun Tae Moon South Korea 22 383 0.9× 382 1.2× 210 1.1× 194 1.2× 300 2.1× 43 1.1k
Bhavani Krishnan United States 10 298 0.7× 231 0.7× 248 1.3× 143 0.9× 89 0.6× 13 1.1k
Bart J. Crielaard Netherlands 18 463 1.1× 262 0.8× 180 1.0× 85 0.5× 72 0.5× 24 1.3k
Nancy Martin United States 18 393 0.9× 203 0.6× 127 0.7× 215 1.3× 76 0.5× 47 2.4k
Elizabeth D. Hood United States 24 543 1.3× 439 1.4× 455 2.4× 114 0.7× 76 0.5× 46 1.6k
Nina Mann United States 9 582 1.3× 370 1.2× 247 1.3× 106 0.7× 54 0.4× 24 1.2k
Seung Rim Hwang South Korea 16 569 1.3× 185 0.6× 202 1.1× 54 0.3× 146 1.0× 38 1.0k
Raffaele Allevi Italy 20 415 1.0× 283 0.9× 323 1.7× 95 0.6× 64 0.4× 35 1.1k
Hsin‐I Chang Taiwan 19 521 1.2× 599 1.9× 383 2.1× 123 0.8× 180 1.2× 47 1.5k

Countries citing papers authored by Mei Lin Tan

Since Specialization
Citations

This map shows the geographic impact of Mei Lin Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Lin Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Lin Tan more than expected).

Fields of papers citing papers by Mei Lin Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Lin Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Lin Tan. The network helps show where Mei Lin Tan may publish in the future.

Co-authorship network of co-authors of Mei Lin Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Lin Tan. A scholar is included among the top collaborators of Mei Lin Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Lin Tan. Mei Lin Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Mei Lin, et al.. (2024). PREDICTIVE VALUE OF CARDIOMETABOLIC INDEX IN CHINESE ADOLESCENTS AGED 12–18 YEARS OLD FOR METABOLICALLY UNHEALTHY PHENOTYPE IN NORMAL WEIGHT POPULATION. Journal of Hypertension. 42(Suppl 1). e101–e101. 1 indexed citations
2.
Qin, Song, Junya Liu, Kun Yu, et al.. (2024). Gpnmb silencing protects against hyperoxia-induced acute lung injury by inhibition of mitochondrial-mediated apoptosis. Human & Experimental Toxicology. 43. 3530241113–3530241113. 2 indexed citations
3.
Ma, Li, et al.. (2024). The novel HLA‐B*15:02:15 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA. 103(5). e15507–e15507. 1 indexed citations
4.
Wu, Liu-Song, Xi Luo, Mei Lin Tan, et al.. (2024). Prevalence of thalassemia-carrier couples and fertility risk assessment. International Journal of Hematology. 119(4). 374–382. 4 indexed citations
5.
Tan, Mei Lin, Xiangmei Zhang, Yuhang Yang, et al.. (2021). Early genetic screening uncovered a high prevalence of thalassemia among 18 309 neonates in Guizhou, China. Clinical Genetics. 99(5). 704–712. 16 indexed citations
6.
Li, Gen, Bo Zhang, Qi Liu, et al.. (2021). A non-invasive real-time monitoring system for cytotoxic brain edema in post ischemic stroke based on near-field coupling. Technology and Health Care. 29(5). 963–978. 3 indexed citations
7.
Wu, Liu-Song, Zhiyu Peng, Sen Lu, et al.. (2017). β-thalassemia caused by compound heterozygous mutations and cured by bone marrow transplantation: A case report. Molecular Medicine Reports. 16(5). 6552–6557. 1 indexed citations
8.
Tan, Mei Lin, et al.. (2017). [Variation of LNK Gene in Chronic Myeloid Leukemia].. PubMed. 25(3). 706–710. 2 indexed citations
9.
Broadhead, Matthew L., Zerina Lokmic‐Tomkins, Mei Lin Tan, et al.. (2015). Applying Advanced Imaging Techniques to a Murine Model of Orthotopic Osteosarcoma. Frontiers in Surgery. 2. 36–36. 4 indexed citations
10.
Tan, Mei Lin, Peng Shao, Anna Friedhuber, et al.. (2014). The potential role of free chitosan in bone trauma and bone cancer management. Biomaterials. 35(27). 7828–7838. 47 indexed citations
11.
Tan, Mei Lin, Dave E. Dunstan, Anna Friedhuber, Peter Choong, & Crispin R. Dass. (2010). A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site. Journal of Controlled Release. 144(2). 196–202. 21 indexed citations
12.
Dass, Crispin R., et al.. (2010). Dz13 Induces a Cytotoxic Stress Response with Upregulation of E2F1 in Tumor Cells Metastasizing to or from Bone. Oligonucleotides. 20(2). 79–91. 9 indexed citations
13.
Tan, Mei Lin, Peter Choong, & Crispin R. Dass. (2010). Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion. Biochemical and Biophysical Research Communications. 398(4). 613–618. 41 indexed citations
14.
Tan, Mei Lin, Peter Choong, & Crispin R. Dass. (2010). Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours. Cancer Cell International. 10(1). 9–9. 24 indexed citations
15.
Tan, Mei Lin, Peter Choong, & Crispin R Dass. (2009). Osteosarcoma – conventional treatment vs. gene therapy. Cancer Biology & Therapy. 8(2). 106–117. 84 indexed citations
16.
Tan, Mei Lin, Peter Choong, & Crispin R. Dass. (2009). DNAzyme Delivery Systems: Getting Past First Base. Expert Opinion on Drug Delivery. 6(2). 127–138. 32 indexed citations
17.
Tan, Mei Lin, Peter Choong, & Crispin R. Dass. (2009). Review: doxorubicin delivery systems based on chitosan for cancer therapy. Journal of Pharmacy and Pharmacology. 61(2). 131–142. 97 indexed citations
18.
Tan, Mei Lin, Anna Friedhuber, Dave E. Dunstan, Peter Choong, & Crispin R. Dass. (2009). The performance of doxorubicin encapsulated in chitosan–dextran sulphate microparticles in an osteosarcoma model. Biomaterials. 31(3). 541–551. 60 indexed citations
19.
Tan, Mei Lin, Peter Choong, & Crispin R. Dass. (2008). Cancer, chitosan nanoparticles and catalytic nucleic acids. Journal of Pharmacy and Pharmacology. 61(1). 3–12. 12 indexed citations
20.
Mannix, Rebekah, Mei Lin Tan, Robert O. Wright, & Marc N. Baskin. (2006). Acute Pediatric Rhabdomyolysis: Causes and Rates of Renal Failure. PEDIATRICS. 118(5). 2119–2125. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026